Global Cushing's Disease Treatment Market Size, Status and Forecast 2021-2027
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cushing's Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ketoconazole
1.2.3 Mitotane
1.2.4 Aminoglutethimide
1.2.5 Metyrapone
1.2.6 Mifepristone
1.2.7 Etomidate
1.2.8 Pasireotide
1.3 Market by Application
1.3.1 Global Cushing's Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Clinics
1.3.6 E-Commerce/Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cushing's Disease Treatment Market Perspective (2016-2027)
2.2 Cushing's Disease Treatment Growth Trends by Regions
2.2.1 Cushing's Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cushing's Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Cushing's Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Cushing's Disease Treatment Industry Dynamic
2.3.1 Cushing's Disease Treatment Market Trends
2.3.2 Cushing's Disease Treatment Market Drivers
2.3.3 Cushing's Disease Treatment Market Challenges
2.3.4 Cushing's Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cushing's Disease Treatment Players by Revenue
3.1.1 Global Top Cushing's Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Cushing's Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Cushing's Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cushing's Disease Treatment Revenue
3.4 Global Cushing's Disease Treatment Market Concentration Ratio
3.4.1 Global Cushing's Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cushing's Disease Treatment Revenue in 2020
3.5 Cushing's Disease Treatment Key Players Head office and Area Served
3.6 Key Players Cushing's Disease Treatment Product Solution and Service
3.7 Date of Enter into Cushing's Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cushing's Disease Treatment Breakdown Data by Type
4.1 Global Cushing's Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Cushing's Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Cushing's Disease Treatment Breakdown Data by Application
5.1 Global Cushing's Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Cushing's Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cushing's Disease Treatment Market Size (2016-2027)
6.2 North America Cushing's Disease Treatment Market Size by Type
6.2.1 North America Cushing's Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Cushing's Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Cushing's Disease Treatment Market Size by Type (2016-2027)
6.3 North America Cushing's Disease Treatment Market Size by Application
6.3.1 North America Cushing's Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Cushing's Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Cushing's Disease Treatment Market Size by Application (2016-2027)
6.4 North America Cushing's Disease Treatment Market Size by Country
6.4.1 North America Cushing's Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Cushing's Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cushing's Disease Treatment Market Size (2016-2027)
7.2 Europe Cushing's Disease Treatment Market Size by Type
7.2.1 Europe Cushing's Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Cushing's Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Cushing's Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Cushing's Disease Treatment Market Size by Application
7.3.1 Europe Cushing's Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Cushing's Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Cushing's Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Cushing's Disease Treatment Market Size by Country
7.4.1 Europe Cushing's Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Cushing's Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cushing's Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Cushing's Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Cushing's Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cushing's Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cushing's Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Cushing's Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Cushing's Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cushing's Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cushing's Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Cushing's Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Cushing's Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cushing's Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cushing's Disease Treatment Market Size (2016-2027)
9.2 Latin America Cushing's Disease Treatment Market Size by Type
9.2.1 Latin America Cushing's Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Cushing's Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Cushing's Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Cushing's Disease Treatment Market Size by Application
9.3.1 Latin America Cushing's Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Cushing's Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Cushing's Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Cushing's Disease Treatment Market Size by Country
9.4.1 Latin America Cushing's Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Cushing's Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cushing's Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Cushing's Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Cushing's Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cushing's Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cushing's Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Cushing's Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Cushing's Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cushing's Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cushing's Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Cushing's Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Cushing's Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cushing's Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 CORCEPT THERAPEUTICS
11.1.1 CORCEPT THERAPEUTICS Company Details
11.1.2 CORCEPT THERAPEUTICS Business Overview
11.1.3 CORCEPT THERAPEUTICS Cushing's Disease Treatment Introduction
11.1.4 CORCEPT THERAPEUTICS Revenue in Cushing's Disease Treatment Business (2016-2021)
11.1.5 CORCEPT THERAPEUTICS Recent Development
11.2 HRA Pharma
11.2.1 HRA Pharma Company Details
11.2.2 HRA Pharma Business Overview
11.2.3 HRA Pharma Cushing's Disease Treatment Introduction
11.2.4 HRA Pharma Revenue in Cushing's Disease Treatment Business (2016-2021)
11.2.5 HRA Pharma Recent Development
11.3 Strongbridge Biopharma
11.3.1 Strongbridge Biopharma Company Details
11.3.2 Strongbridge Biopharma Business Overview
11.3.3 Strongbridge Biopharma Cushing's Disease Treatment Introduction
11.3.4 Strongbridge Biopharma Revenue in Cushing's Disease Treatment Business (2016-2021)
11.3.5 Strongbridge Biopharma Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cushing's Disease Treatment Introduction
11.4.4 Novartis Revenue in Cushing's Disease Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Cushing's Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ketoconazole
Table 3. Key Players of Mitotane
Table 4. Key Players of Aminoglutethimide
Table 5. Key Players of Metyrapone
Table 6. Key Players of Mifepristone
Table 7. Key Players of Etomidate
Table 8. Key Players of Pasireotide
Table 9. Global Cushing's Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Cushing's Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Cushing's Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Cushing's Disease Treatment Market Share by Regions (2016-2021)
Table 13. Global Cushing's Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Cushing's Disease Treatment Market Share by Regions (2022-2027)
Table 15. Cushing's Disease Treatment Market Trends
Table 16. Cushing's Disease Treatment Market Drivers
Table 17. Cushing's Disease Treatment Market Challenges
Table 18. Cushing's Disease Treatment Market Restraints
Table 19. Global Cushing's Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Cushing's Disease Treatment Market Share by Players (2016-2021)
Table 21. Global Top Cushing's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cushing's Disease Treatment as of 2020)
Table 22. Ranking of Global Top Cushing's Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Cushing's Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cushing's Disease Treatment Product Solution and Service
Table 26. Date of Enter into Cushing's Disease Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cushing's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Cushing's Disease Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Cushing's Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Cushing's Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Cushing's Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Cushing's Disease Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Cushing's Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Cushing's Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Cushing's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Cushing's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Cushing's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Cushing's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Cushing's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Cushing's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Cushing's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Cushing's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Cushing's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Cushing's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Cushing's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Cushing's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cushing's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cushing's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cushing's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Cushing's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Cushing's Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Cushing's Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Cushing's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Cushing's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Cushing's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Cushing's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Cushing's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Cushing's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cushing's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cushing's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cushing's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Cushing's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Cushing's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Cushing's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. CORCEPT THERAPEUTICS Company Details
Table 67. CORCEPT THERAPEUTICS Business Overview
Table 68. CORCEPT THERAPEUTICS Cushing's Disease Treatment Product
Table 69. CORCEPT THERAPEUTICS Revenue in Cushing's Disease Treatment Business (2016-2021) & (US$ Million)
Table 70. CORCEPT THERAPEUTICS Recent Development
Table 71. HRA Pharma Company Details
Table 72. HRA Pharma Business Overview
Table 73. HRA Pharma Cushing's Disease Treatment Product
Table 74. HRA Pharma Revenue in Cushing's Disease Treatment Business (2016-2021) & (US$ Million)
Table 75. HRA Pharma Recent Development
Table 76. Strongbridge Biopharma Company Details
Table 77. Strongbridge Biopharma Business Overview
Table 78. Strongbridge Biopharma Cushing's Disease Treatment Product
Table 79. Strongbridge Biopharma Revenue in Cushing's Disease Treatment Business (2016-2021) & (US$ Million)
Table 80. Strongbridge Biopharma Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Cushing's Disease Treatment Product
Table 84. Novartis Revenue in Cushing's Disease Treatment Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Cushing's Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Ketoconazole Features
Figure 3. Mitotane Features
Figure 4. Aminoglutethimide Features
Figure 5. Metyrapone Features
Figure 6. Mifepristone Features
Figure 7. Etomidate Features
Figure 8. Pasireotide Features
Figure 9. Global Cushing's Disease Treatment Market Share by Application: 2020 VS 2027
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Drug Stores Case Studies
Figure 13. Clinics Case Studies
Figure 14. E-Commerce/Online Pharmacies Case Studies
Figure 15. Cushing's Disease Treatment Report Years Considered
Figure 16. Global Cushing's Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Cushing's Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Cushing's Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 19. Global Cushing's Disease Treatment Market Share by Regions (2022-2027)
Figure 20. Global Cushing's Disease Treatment Market Share by Players in 2020
Figure 21. Global Top Cushing's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cushing's Disease Treatment as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Cushing's Disease Treatment Revenue in 2020
Figure 23. Global Cushing's Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 24. Global Cushing's Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 25. North America Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Cushing's Disease Treatment Market Share by Type (2016-2027)
Figure 27. North America Cushing's Disease Treatment Market Share by Application (2016-2027)
Figure 28. North America Cushing's Disease Treatment Market Share by Country (2016-2027)
Figure 29. United States Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Cushing's Disease Treatment Market Share by Type (2016-2027)
Figure 33. Europe Cushing's Disease Treatment Market Share by Application (2016-2027)
Figure 34. Europe Cushing's Disease Treatment Market Share by Country (2016-2027)
Figure 35. Germany Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Cushing's Disease Treatment Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Cushing's Disease Treatment Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Cushing's Disease Treatment Market Share by Region (2016-2027)
Figure 45. China Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Cushing's Disease Treatment Market Share by Type (2016-2027)
Figure 53. Latin America Cushing's Disease Treatment Market Share by Application (2016-2027)
Figure 54. Latin America Cushing's Disease Treatment Market Share by Country (2016-2027)
Figure 55. Mexico Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Cushing's Disease Treatment Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Cushing's Disease Treatment Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Cushing's Disease Treatment Market Share by Country (2016-2027)
Figure 61. Turkey Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Cushing's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. CORCEPT THERAPEUTICS Revenue Growth Rate in Cushing's Disease Treatment Business (2016-2021)
Figure 65. HRA Pharma Revenue Growth Rate in Cushing's Disease Treatment Business (2016-2021)
Figure 66. Strongbridge Biopharma Revenue Growth Rate in Cushing's Disease Treatment Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Cushing's Disease Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed